Gene · 7832
Papers2,269
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,269
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sequential lymphoid neoplasms mimicking relapse of mediastinal grey zone lymphoma in a patient with germline variants in EP300 and PTPRK. | Virchows Arch | 2026 | 42809123 | PubTator, text mining | PubMed |
| Craniofacial Involvement Is Associated With Poor Prognosis in Extranodal Diffuse Large B-Cell Lymphoma. | Hematol Oncol | 2026 | 42781756 | PubTator, text mining | PubMed |
| Research progress on BTG2 in non‑tumor diseases (Review). | Int J Mol Med | 2026 | 42663296 | PubTator, text mining | PubMed |
| [Analysis of the Gene Mutation Distribution and Its Relationship with Prognosis in Patients with Primary Gastrointestinal Diffuse Large B-Cell Lymphoma by Next Generation Sequencing]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2026 | 42544655 | PubTator, text mining | PubMed |
| Diagnostic potential of B-cell translocation gene 2 in IgA nephropathy: Insights from molecular mechanisms. | J Cell Commun Signal | 2026 | 42518875 | PubTator, text mining | PubMed |
| Bioinformatics reveals the prognostic potential of manganese metabolism-related genes in lung adenocarcinoma. | Funct Integr Genomics | 2026 | 42472729 | PubTator, text mining | PubMed |
| Causal association and shared mechanisms between Graves' disease and prostate cancer: insights from Mendelian randomization, machine learning, and comprehensive bioinformatics. | Aging Male | 2026 | 42454507 | PubTator, text mining | PubMed |
| Aberrant O-glycosylation genes and miR-21-5p targets define a molecular signature of tumor aggressiveness in triple-negative breast cancer. | Glycobiology | 2026 | 42348735 | PubTator, text mining | PubMed |
| Research and development of novel embolization materials and study on their feasibility of preventing T2EL after EVAR abdominal aortic aneurysm. | Front Cardiovasc Med | 2026 | 42306591 | PubTator, text mining | PubMed |
| Identification and Characterization of MicroRNAs Associated with Borax-mediated Anti-tumor Activity through High-throughput Technology. | Curr Mol Med | 2026 | 42304903 | PubTator, text mining | PubMed |
| Thymoquinone inhibits proliferation and impairs wound closure dynamics via apoptosis and autophagy-related pathways in multiple cancer cell lines. | Mol Biol Rep | 2026 | 42171850 | PubTator, text mining | PubMed |
| PC3/Tis21/BTG2 and BTG1 genes: regulators of the cell cycle and neurogenesis, as well as tumor suppressors in malignant brain tumors. | Front Cell Dev Biol | 2026 | 42080092 | PubTator, text mining | PubMed |
| PPy-coated wire actuators for micromechanostimulation of cells - identification of immediate-early responsive mechanoregulatory genes in osteoblasts. | Bone | 2026 | 42069275 | PubTator, text mining | PubMed |
| Integrating network toxicology and experimental validation to elucidate the molecular mechanism basis of chondrotoxicity of Benzo[a]pyrene in osteoarthritis. | Ecotoxicol Environ Saf | 2026 | 42034589 | PubTator, text mining | PubMed |
| Urinary extracellular vesicle miRNA signature reflects pancreatic islet stress in type 2 diabetes. | J Diabetes Investig | 2026 | 42017432 | PubTator, text mining | PubMed |
| p53 safeguards chemical reprogramming of human somatic cells toward pluripotency. | Cell | 2026 | 41999746 | PubTator, text mining | PubMed |
| Circulating MicroRNA Profiling for Phenotypic Stratification in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease: A Candidate-Based Study. | Curr Issues Mol Biol | 2026 | 41899424 | PubTator, text mining | PubMed |
| T-2 Toxin Neurotoxicity: Molecular Mechanisms and Emerging Chemoprotective Strategies. | Antioxidants (Basel) | 2026 | 41897425 | PubTator, text mining | PubMed |
| Short and Long Non-Coding RNAs in Renal Cell Carcinoma. | Noncoding RNA | 2026 | 41874142 | PubTator, text mining | PubMed |
| Beyond blacklists: a critical assessment of exclusion set generation strategies and alternative approaches. | Bioinformatics | 2026 | 41826793 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7832/papers